Skip to content
Unrated Drug recall · FDA · Published September 24, 2025

Zydus Entecavir Tablets Recall: Impurity Risk in 0.5mg Dose

Zydus Pharmaceuticals recalls 0.5mg Entecavir tablets due to failed impurity tests. This medication is prescription-only and may contain unsafe levels of organic impurities.

🇺🇸 FDA recall #D-0001-2026DrugZydus Pharmaceuticals ›
Take action

Contact the company

Recalling firmZydus Pharmaceuticals (USA) Inc73 Route 31 N · Pennington, NJ 08534-3601
✎ GovInfoNow plain-language explainer

Zydus Pharmaceuticals is recalling prescription Entecavir tablets after testing found unsafe levels of an organic impurity. This could pose a health risk to patients taking the medication. Read more at govinfonow.com/recall/31770-zydus-entecavir-tablets-recall-impurity-risk-in-0-5mg-dose.

Source Summary by GovInfoNow · govinfonow.com/recall/31770-zydus-entecavir-tablets-recall-impurity-risk-in-0-5mg-dose · Updated August 17, 2026 · FDA enforcement record: FDA #D-0001-2026

Cite this page

“Zydus Entecavir Tablets Recall: Impurity Risk in 0.5mg Dose.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31770-zydus-entecavir-tablets-recall-impurity-risk-in-0-5mg-dose. Based on FDA recall #D-0001-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0001-2026%22&limit=1).

The FDA announced on September 24, 2025, that Zydus Pharmaceuticals (USA) Inc is recalling Entecavir Tablets, USP, 0.5 mg due to failed impurity specifications. The recall affects 912 bottles distributed nationwide.

How to tell if you have it

  • Brand: Zydus Pharmaceuticals
  • Product: Entecavir Tablets, USP, 0.5 mg, 30-count bottle
  • NDC: 68382-920-06
  • Lot Code: E409308
  • Expiration Date: 12/31/2026
  • Quantity: 912 units

The hazard

The recall is due to an out-of-specification result for an individual organic impurity. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Zydus Pharmaceuticals (USA) Inc has 53 other recalls on record since March 14, 2012. Recent Zydus recalls include Mirabegron tablets on August 5, 2026, and Erythromycin tablets on April 29, 2026, both involving N-Nitroso impurity risks. Other recent recalls of similar products include JB Chemicals Enalapril tablets (April 23, 2026), Alembic Fesoterodine Tablets (December 16, 2025), and Unichem Bisoprolol/Hydrochlorothiazide Tablets (January 21, 2026).

How to tell if you have this one

Check for the 0.5 mg dose, 30-count bottle, and prescription label. The product was manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India and distributed by Zydus Pharmaceuticals (USA) Inc.

  • Brand
    Zydus Pharmaceuticals
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Distributed Nationwide in the USA
  • NDC
    68382-920-06, 68382-920-16, 68382-920-01, 68382-920-30, 68382-920-77, 68382-921-06, 68382-921-16, 68382-921-01, 68382-921-30, 68382-921-77
Recall numberProduct, codes & lotsQuantity
D-0001-2026Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.; Lot#: E409308, Exp 12/31/2026912 30-count bottles
D-0002-2026Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.; Lot#: E409309, Exp 12/31/2026600 30-count bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Verify the product label shows 0.5 mg, 30-count, and prescription-only status.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 14 days after the firm started it.

1. Firm started the recall: Sep 24, 202512. FDA classified it Class II: Oct 2, 202523. Published in FDA’s Enforcement Report: Oct 8, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the expiration date?

The product expires December 31, 2026, as indicated on the label.

Similar recalls

Other Zydus Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0001-2026 (September 24, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0001-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA